Planning Strategies’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.06K Buy
29
+12
+71% +$435 ﹤0.01% 779
2026
Q2
$602 Hold
17
– – ﹤0.01% 826

Other funds holding ROIV

Planning Strategies's ROIV Position: Q3 2026 in Review

Planning Strategies increased its Roivant Sciences (ROIV) stake by 71% in Q3 2026, buying an estimated $435 and bringing the position to 29 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #779.

Planning Strategies first reported a position in ROIV in Q2 2026 and has held it in 2 quarters since. 522 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Planning Strategies held 29 shares of Roivant Sciences worth $1.06K as of Q3 2026.
  • Planning Strategies bought 12 Roivant Sciences shares in Q3 2026, an estimated $435.
  • Roivant Sciences made up ﹤0.01% of Planning Strategies's portfolio in Q3 2026, its #779 holding.
  • Planning Strategies first reported a position in Roivant Sciences in Q2 2026 and has held it in 2 quarters since.
  • 522 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.